CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Álvaro Teijeira(Navarre Institute of Health Research), Ignacio Melero(Universidad de Navarra)
Cited by 749
Related Papers
Cytokines in clinical cancer immunotherapy
|British Journal of Cancer|2018|1.2k
Immunostimulatory monoclonal antibodies for cancer therapy
|Nature reviews. Cancer|2007|628
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
|Nature Reviews Clinical Oncology|2021|469
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
|Clinical Cancer Research|2020|109
Cellular cytotoxicity is a form of immunogenic cell death
|Journal for ImmunoTherapy of Cancer|2020|93